N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide
- CAS No.
- 23812-97-7
- Chemical Name:
- N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide
- Synonyms
- Lankacidin C 8-acetate;N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide;Propanamide, N-[7-(acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxo-, [1S-(1R*,2S*,3E,5E,7R*,9E,11E,13R*,15S*,19S*)]- (9CI)
- CBNumber:
- CB72147180
- Molecular Formula:
- C27H35NO8
- Molecular Weight:
- 501.57
- MDL Number:
- MOL File:
- 23812-97-7.mol
Last updated:2022-12-21 16:56:50
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide Properties
FDA UNII | 6PL6MYG9NI |
---|
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide Preparation Products And Raw materials
Raw materials
Preparation Products
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide Suppliers
Global( 1)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
Supplier | Advantage |
---|---|
TargetMol Chemicals Inc. | 58 |
Lankacidin C 8-acetate
N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide
Propanamide, N-[7-(acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxo-, [1S-(1R*,2S*,3E,5E,7R*,9E,11E,13R*,15S*,19S*)]- (9CI)
23812-97-7